Literature DB >> 7827241

Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada).

H A Risch1, M Jain, L D Marrett, G R Howe.   

Abstract

A case-control study of dietary factors and cancer of the ovary was conducted during 1989-92 in metropolitan Toronto and surrounding areas of southern Ontario, Canada. Four hundred and fifty women aged 35-79 years, with newly diagnosed, histologically verified, primary epithelial ovarian-cancer were interviewed concerning reproduction and diet. Over the same period, 564 randomly-selected population controls, frequency-matched to the cases within three 15-year age groups, also were interviewed. From information obtained by quantitative diet history, average daily macro- and micronutrient intake values were calculated through use of the United States Department of Agriculture Food Composition Databank, which was extended and modified for Canadian items and recipes. Analysis was performed with continuous, unconditional logistic-regression methods, adjusting for age at interview, number of full-term pregnancies, total duration of oral contraceptive use, and total daily caloric intake. Neither reported history of lactose intolerance, nor average daily consumption of lactose or free galactose, were found to be associated with risk of ovarian cancer. Lactose intake or intolerance did not appear to modify the protective effects of parity and oral contraceptive use. Nevertheless, other studies suggest that ovarian galactose metabolism still may have a relationship with risk of ovarian cancer, though more evidence is needed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827241     DOI: 10.1007/bf01831382

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  43 in total

Review 1.  Regulation of galactose metabolism: implications for therapy.

Authors:  S Segal; S Rogers
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia.

Authors:  I S Fraser; P Russell; S Greco; D M Robertson
Journal:  Clin Reprod Fertil       Date:  1986-04

3.  Commentary: re: "A case-control study of milk drinking and ovarian cancer risk".

Authors:  D W Cramer; B L Harlow
Journal:  Am J Epidemiol       Date:  1991-09-01       Impact factor: 4.897

4.  Dietary factors and risk of pancreatic cancer: results of a Canadian population-based case-control study.

Authors:  G R Howe; M Jain; A B Miller
Journal:  Int J Cancer       Date:  1990-04-15       Impact factor: 7.396

5.  Galactose metabolism in human ovarian tissue.

Authors:  Y K Xu; W G Ng; F R Kaufman; R A Lobo; G N Donnell
Journal:  Pediatr Res       Date:  1989-02       Impact factor: 3.756

6.  Reproductive, genetic, and dietary risk factors for ovarian cancer.

Authors:  M Mori; I Harabuchi; H Miyake; J T Casagrande; B E Henderson; R K Ross
Journal:  Am J Epidemiol       Date:  1988-10       Impact factor: 4.897

7.  Galactose-1-phosphate uridyl transferase activity associated with age at menopause and reproductive history.

Authors:  D W Cramer; B L Harlow; R L Barbieri; W G Ng
Journal:  Fertil Steril       Date:  1989-04       Impact factor: 7.329

8.  Lactase persistence and milk consumption as determinants of ovarian cancer risk.

Authors:  D W Cramer
Journal:  Am J Epidemiol       Date:  1989-11       Impact factor: 4.897

9.  Diet and ovarian cancer: a case-control study in Greece.

Authors:  A Tzonou; C C Hsieh; A Polychronopoulou; G Kaprinis; N Toupadaki; A Trichopoulou; A Karakatsani; D Trichopoulos
Journal:  Int J Cancer       Date:  1993-09-30       Impact factor: 7.396

10.  Gonadal function and ovarian galactose metabolism in classic galactosemia.

Authors:  F R Kaufman; Y K Xu; W G Ng; P D Silva; R A Lobo; G N Donnell
Journal:  Acta Endocrinol (Copenh)       Date:  1989-02
View more
  1 in total

1.  Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes.

Authors:  Melissa A Merritt; Daniel W Cramer; Allison F Vitonis; Linda J Titus; Kathryn L Terry
Journal:  Int J Cancer       Date:  2012-07-24       Impact factor: 7.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.